Raj Chovatiya, MD, PhD: Repigmentation of Vitiligo Using Topical Therapies
Dr. Chovatiya discusses how topical ruxolitibnib cream has the ability to not only stop depigmentation but help induce repigmentation by stopping the inflammatory process and allowing melanocytes back into the skin.
Peter Lio, MD, FAAD: Sustainable Improvements for Patients with Atopic Dermatitis
Dr. Lio discusses the effects of topical ruxolitinib in his patients with atopic dermatitis, and how he incorporates this treatment into his practice.
Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo
Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s vitiligo toolkit.
Adam Friedman, MD, FAAD: Matching Patients to the Right Treatments for Atopic Dermatitis
Dr. Friedman discusses how to evaluate patients with atopic dermatitis to match them with their best treatment as well as the importance of keeping a detailed patient history in order to improve ease of access to the most effective medications.
Raj Chovatiya, MD, PhD: Itch in Atopic Dermatitis
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses how to distinguish when to use topical versus oral therapy in patients with atopic dermatitis.